Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 147-155

  Papapetropoulos, Andreas ^a   Go, Carolyn Y ^a   Murad, Ferid ^b   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Molecular Geriatrics Corporation   (United States)

Author keywords

Cyclic GMP; Protein kinase A; Sodium nitroprusside; Soluble guanylate cyclase; Tolerance

Indexed keywords

8 BROMO CYCLIC GMP; ANTIHYPERTENSIVE AGENT; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANYLATE CYCLASE; MESSENGER RNA; N ACETYLPENICILLAMINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OXYHEMOGLOBIN; PHOSPHODIESTERASE INHIBITOR; REDUCING AGENT; THIOL; ZAPRINAST;

ANIMAL CELL; AORTA; ARTERY MUSCLE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG TOLERANCE; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

EID: 0030052615     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15167.x     Document Type: Article

References (44)

1. AXELSSON, K.L., AHLNER, J. & LJUSEGREN, M.E. (1986). Tolerance to organic nitroesters in experimental animals. An assessment of in vitro and in vivo investigations. Acta Pharmacol. Toxicol., 59 (Suppl. VI), 121-128.
2. BERGSTRAND, H., KRISTOFFERSON, J., LUNDQUIST, B. & SCHURMANN (1977). Effects of antiallergic agents, compound 40/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine 3′, 5′ cyclic monophosphate and guanosine 3′, 5′ cyclic monophosphate phosphodiesterases. Mol. Pharmacol., 13, 38-45.
3. BRADFORD, M. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-253.
4. BRANDWEIN, H.J., LEWICKI, J.A. & MURAD, F. (1981). Reversible inactivation of guanylate cyclase by mixed disulfide formation. J. Biol. Chem., 256, 2958-2962.
5. BRAUGHLER, J.M. (1983). Soluble guanylate cyclase activation by nitric oxide and its reversal. Biochem. Pharmacol., 32, 811-818.
6. BROOKER, G., TERASAKI, W. & PRICE, M. (1976). Gammaflow: a completely automated radioimmunoassay system. Science, 194, 270-276.
7. BUECHLER, W.A., NAKANE, M. & MURAD, F. (1991). Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem. Biophys. Res. Commun., 174, 351-357.
8. CHIJIWA, T., MISHIMA, A., HAGIWARA, M., SANO, M., HAYASHI, K., INOUE, T., NAITO, K., TASHIOKA, T. & HIDAKA, H. (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cAMP-dependent protein kinase, N-[2-p-(bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H89), of PC12 pheochromocytoma cells. J. Biol. Chem., 265, 5267-5272.
9. GEISTERFER, A.A.T., PEACH, M.J. & OWENS, G.K. (1988). Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res., 62, 749-756.
10. GIUILI, G., SCHOLL, U., BULLE, F. & GUELLAEN, G. (1992). Molecular cloning of the cDNAs coding for the two subunits of the soluble guanylyl cyclase from human brain. FEBS Lett., 304 83-88.
11. GRUETTER, C.A., BARRY, B.K., MCNAMARA, D.B., GRUETTER, D.Y., KADOWITZ, P.J. & IGNARRO, L.J. (1979). Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J. Cyclic Nucleotide Res., 5, 211.
12. HARTENECK, C., WEDEL, B., KOESLING, D., MALKEWITZ, J., BOHME, F. & SCHULTZ G. (1991). Molecular cloning of a new alpha subunit of soluble guanylate cyclase. Interchangeability of the alpha-subunits of the enzyme. FEBS Lett., 292, 217-222.
13. HENRY, P.J., DRUMMER, O.H. & HOROWITZ, J.D. (1989a). S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators. Br. J. Pharmacol., 98, 757-766.
14. HENRY, P.J., HOROWITZ, J.D. & LOUIS, W.J. (1989b). Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade. J. Pharmacol. Exp. Ther., 248, 762-768.
15. HUNTER, W.M. & GREENWOOD, F.C. (1962). Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature, 194, 495-496.
16. IGNARRO, L.J. & KADOWITZ, P.J. (1985). Pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol., 25, 171-191.
17. KAMISAKI, Y., WALDMAN, S.A. & MURAD, F. (1986). The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside. Arch. Biochem. Biophys., 251, 709-714.
18. KATSUKI, S., ARNOLD, W., MITTAL, C. & MURAD, F. (1977). Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res., 3, 23-35.
19. KOJDA, G., MEYER, W. & NOACK, E. (1993). Influence of endothelium and nitrovasodilators on free thiols and disulfides in porcine coronary artery smooth muscle. Eur. J. Pharmacol., 250, 385-394.
20. KOJDA, G., BECK, J.K., MEYER, W. & NOACK, E. (1994). Nitrovasodilator-induced relaxation and tolerance development in porcine vena cordis magna: dependence on intact endothelium. Br. J. Pharmacol., 112, 533-540.
21. KOMAS, N., LUGNIER, C. & STOCLET, J-C. (1991). Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br. J. Pharmacol., 104, 495-503.
22. KOUREMBANAS, S., McQUILLAN, L.P., LEUNG, G.K & FALLER, D.V. (1993). Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin Invest., 92, 99-104.
23. LEWICKI, J.A., CHANG, B. & MURAD, K. (1983). Quantification of guanylate cyclase concentrations by a direct double determinant tandem immunoradiometric assay. J. Biol. Chem., 258, 3509-3515.
24. LINCOLN, T.M. & CORNWELL, T.L. (1993). Intracellular cyclic GMP receptor proteins. FASEB J., 7, 328-338.
25. MAGRINAT, G., MASON, S.N., SHAMI, P.J. & WEINBERG, J.B. (1992). Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood, 80, 1880-1884.
26. MONCADA, S., REES, D.D., SCHULZ, R. & PALMER, R.M.J. (1991). Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. U.S.A., 88, 2166-2170.
27. MÜNZEL, T., SAYEGH, H., FREEMAN, B.A., TARPEY, M.M. & HARRISON, D.G. (1995). Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism for tolerance and cross-tolerance. J. Clin. Invest., 95, 187-194.
28. NAKANE, M., ARAI, K., SAHEKI, S., KUNO, T., BUECHLER, W. & MURAD, F. (1990). Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J. Biol. Chem., 265, 16841-16845.
29. NAKANE, M., SAHEKI, S., KUNO, T., ISHII, K. & MURAD, K. (1988). Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. Biochem. Biophys. Res. Commun., 157, 1139-1147.
30. NEEDLEMAN, P. & JOHNSON, E.M. (1973). Mechanism of tolerance development to organic nitrates. J. Pharmacol. Exp. Ther., 184, 709-715.
31. PAPAPETROPOULOS, A., MARCZIN, N. & CATRAVAS, J.D. (1993). Prolonged exposure to endothelium-derived relaxing factor attenuates cyclic guanosine monophosphate accumulation in cultured smooth muscle cells. Circulation, 88, 1424 (Abstract).
32. PAPAPETROPOULOS, A., MARCZIN, N., SNEAD, M.D., CHENG, C., MILICI, A. & CATRAVAS, J.D. (1994). Smooth muscle cell to nitrovasodilators in hypertensive and normotensive rats. Hypertension, 23, 476-484.
33. PAPAPETROPOULOS, A., MARCZIN, N., MORA, G., MILICI, A., MURAD, F. & CATRAVAS, J.D. (1995). Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA and protein levels by cAMP-elevating agents. Hypertension, 26, 696-704.
34. 125I-labeled succinyl cyclic nucleotide tyrosine methyl esters by high-performance liquid chromatography. Anal Biochem., 168, 417-420.
35. ROMANIN, C. & KUKOVETZ, W.R. (1989). Tolerance to nitroglycerin is caused by reduced guanylate cyclase activation. J. Mol. Cell Cardiol., 21, 41-48.
36. SEDLAK, J. & LINDSAY, R.H. (1968). Estimation of total, protein bound and nonprotein sulfhydryls groups in tissue with Ellman's reagent. Anal. Biochem., 25, 192-205.
37. 1-subunit gene expression in RFL-6 rat fetal lung fibroblasts. Am. J. Physiol., 265, L456-L461.
38. SHIRASAKI, Y. & SU, C. (1985). Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite. Eur. J. Pharmacol., 114, 93-96.
39. UJIIE, K., DREWETT, J.G., YUEN, P.S.T. & STAR, R.A. (1993). Differential expression of mRNA for guanylyl cyclase-linked endothelium-derived relaxing factor receptor subunits in rat kidney. J. Clin. Invest., 91, 730-734.
40. UJIIE, K., HOGARTH, L., DANZIGER, R., DREWETT, J.G., YUEN, P.S.T., PANG, I.-H. & STAR, R.A. (1994). Homologous and heterologous desensitization of guanylyl cyclase-linked nitric oxide receptor in cultured rat medulary interstitial cells. J. Pharmacol. Exp. Ther., 270, 761-767.
41. WALDMAN, S.A. & MURAD, F. (1987). GMP synthesis and function. Pharmacol. Rev., 39, 163-196.
42. WU, X-B., BRUNE, B., VON APPEN, F. & ULLRICH, V. (1992). Reversible activation of soluble guanylate cyclase by oxidizing agents. Arch. Biochem. Biophys., 294, 75-82.
43. YUEN, P.S.T., POTTER, L.R. & GARBERS, D.L. (1990). A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochem., 29, 10872-10878.
44. ZHANG, L.M., CASTRESANA, M.R., STEFANSSON, S. & NEWMANN, W.H. (1993). Tolerance to sodium nitroprusside. Studies in cultured porcine vascular smooth muscle cells. Anesthesiol., 79, 1094-1103.